Lead party: Vaxxinova International B.V. (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Deltamune (Pty) Limited (private company) · Sector: Healthcare, Pharmaceuticals, Biotechnology · Countries of operation: South Africa
Transaction type: Merger/Acquisition(M&A), Exit · Asset class: Private Equity, Corporate Transactions · Strategy: Secondary Sale · Instrument: Equity
Lead investor/buyer: Vaxxinova International B.V. · Investors/buyers: Vaxxinova International B.V. · Sellers: Phatisa Group Limited
Legal advisers: not identified in the source record.
Source: announced 9 July 2025. Original announcement: phatisa.com.


